HomeNewsWorldJapan may end state of emergency this week for regions with stable coronavirus cases

Japan may end state of emergency this week for regions with stable coronavirus cases

Tokyo, Osaka and 11 other prefectures are not among the regions that could see an earlier easing of restrictions.

May 11, 2020 / 09:36 IST
Story continues below Advertisement

The Japanese government will consider lifting the state of emergency on many of the 34 prefectures that are not among the hardest-hit by the coronavirus epidemic before the nationwide deadline of May 31, Economy Minister Yasutoshi Nishimura said.

Tokyo, Osaka and 11 other prefectures are not among the regions that could see an earlier easing of restrictions.

Story continues below Advertisement

"As for the 34 prefectures ... if we can confirm the number of new infections remains stable, lifting (of the state of emergency) will be in sight for many of those prefectures," Nishimura told a parliament session on Monday.

He added that the emergency could be re-implemented if there were signs of an overshoot after the lifting.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show